{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:33:19Z","timestamp":1790634799657,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ajo.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T23:31:54Z","timestamp":1527291114000},"page":"20-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Macular Structures, Optical Components, and Visual Acuity in Preschool Children after Intravitreal Bevacizumab or Laser Treatment"],"prefix":"10.1016","volume":"192","author":[{"given":"Yung-Sung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Chu","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-7255","authenticated-orcid":false,"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2018.05.002_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.survophthal.2016.12.004","article-title":"Advances in understanding and management of retinopathy of prematurity","volume":"62","author":"Hartnett","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.05.002_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"106","author":"Multicenter trial of cryotherapy for retinopathy of prematurity","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2018.05.002_bib3","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.002_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2018.05.002_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/IAE.0000000000001125","article-title":"Outcomes after laser versus combined laser and bevacizumab treatment for type 1 retinopathy of prematurity in zone I","volume":"37","author":"Yoon","year":"2017","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.002_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1080\/02713683.2016.1264607","article-title":"Comparison of intravitreal bevacizumab, intravitreal ranibizumab and laser photocoagulation for treatment of type 1 retinopathy of prematurity in Turkish preterm children","volume":"42","author":"Kabatas","year":"2017","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.ajo.2018.05.002_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/02713683.2016.1196709","article-title":"Comparison of bevacizumab, ranibizumab, and laser photocoagulation in the treatment of retinopathy of prematurity in Turkey","volume":"42","author":"Gunay","year":"2017","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.ajo.2018.05.002_bib8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2018.05.002_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2018.05.002_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/IAE.0000000000001241","article-title":"Comparison of intravitreal injection of ranibizumab versus laser therapy for zone II treatment-requiring retinopathy of prematurity","volume":"37","author":"Zhang","year":"2017","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2018.05.002_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000439182","article-title":"Refractive error in patients with retinopathy of prematurity after laser photocoagulation or bevacizumab monotherapy","volume":"234","author":"Kuo","year":"2015","journal-title":"Ophthalmologica"},{"issue":"2","key":"10.1016\/j.ajo.2018.05.002_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaapos.2015.01.009","article-title":"Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser","volume":"19","author":"Isaac","year":"2015","journal-title":"J AAPOS"},{"issue":"11","key":"10.1016\/j.ajo.2018.05.002_bib13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.05.002_bib14","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/eye.2014.172","article-title":"Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes","volume":"28","author":"Chen","year":"2014","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.ajo.2018.05.002_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ajo.2013.01.014","article-title":"Intravitreal bevacizumab for retinopathy of prematurity: refractive error results","volume":"155","author":"Harder","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2018.05.002_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaapos.2016.09.013","article-title":"Refractive outcomes following the treatment of retinopathy of prematurity in the anti-VEGF era: a literature review","volume":"20","author":"Abri Aghdam","year":"2016","journal-title":"J AAPOS"},{"issue":"2","key":"10.1016\/j.ajo.2018.05.002_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2017.08.005","article-title":"Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings","volume":"125","author":"Lepore","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2018.05.002_bib18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ophtha.2012.02.040","article-title":"Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity","volume":"119","author":"Wu","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2018.05.002_bib19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jamaophthalmol.2013.5052","article-title":"Choroidal thickness in patients with a history of retinopathy of prematurity","volume":"131","author":"Wu","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2018.05.002_bib20","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ophtha.2013.01.028","article-title":"Subclinical macular findings in infants screened for retinopathy of prematurity with spectral-domain optical coherence tomography","volume":"120","author":"Dubis","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2018.05.002_bib21","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1167\/iovs.10-7155","article-title":"Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography","volume":"52","author":"Vinekar","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2018.05.002_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ophtha.2017.09.020","article-title":"Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity","volume":"125","author":"Vogel","year":"2018","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.002_bib23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2018.05.002_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","article-title":"An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan","volume":"155","author":"Wu","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.05.002_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2014.05.017","article-title":"Foveal structure-function correlation in children with history of retinopathy of prematurity","volume":"158","author":"Villegas","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2018.05.002_bib26","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.ophtha.2011.05.028","article-title":"Dynamics of human foveal development after premature birth","volume":"118","author":"Maldonado","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2018.05.002_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajo.2012.05.007","article-title":"Histologic development of the human fovea from midgestation to maturity","volume":"154","author":"Hendrickson","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.002_bib28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bjophthalmol-2012-301612","article-title":"Foveal avascular zone and foveal pit formation after preterm birth","volume":"96","author":"Yanni","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.002_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archopht.126.7.907","article-title":"Visual insignificance of the foveal pit: reassessment of foveal hypoplasia as fovea plana","volume":"126","author":"Marmor","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2018.05.002_bib30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/IAE.0000000000001168","article-title":"Choroidal thickness in healthy Chinese children aged 6 to 12: The Shanghai Children Eye Study","volume":"37","author":"He","year":"2017","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2018.05.002_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/02713683.2013.867064","article-title":"Changes of choroidal thickness after treatment for diabetic retinopathy","volume":"39","author":"Lee","year":"2014","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2018.05.002_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ajo.2015.12.024","article-title":"Choroidal thickness changes in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study","volume":"164","author":"Ting","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.05.002_bib33","first-page":"365","article-title":"Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone","volume":"101","author":"Mueller","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.05.002_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajo.2017.04.010","article-title":"Anterior chamber angle and anterior segment structure of eyes in children with early stages of retinopathy of prematurity","volume":"179","author":"Chang","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.05.002_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12886-015-0099-7","article-title":"Acute angle-closure glaucoma in retinopathy of prematurity following pupil dilation","volume":"15","author":"Wu","year":"2015","journal-title":"BMC Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.05.002_bib36","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.15-18843","article-title":"OCT-based macular structure-function correlation in dependence on birth weight and gestational age - the Giessen Long-Term ROP Study","volume":"57","author":"Bowl","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2018.05.002_bib37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/eye.2015.166","article-title":"Retinal nerve fiber layer thickness in prematurity is correlated with stage of retinopathy of prematurity","volume":"29","author":"Park","year":"2015","journal-title":"Eye (Lond)"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418302125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418302125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:36:36Z","timestamp":1757597796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418302125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S0002939418302125"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.05.002","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macular Structures, Optical Components, and Visual Acuity in Preschool Children after Intravitreal Bevacizumab or Laser Treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}